Concert Pharmaceuticals Inc
F:73C
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is 73C's stock price target?
Not Available
73C doesn't have any price targets made by Wall Street professionals.
What is Concert Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
-89%
For the last 8 years the compound annual growth rate for Concert Pharmaceuticals Inc's revenue is 3%. The projected CAGR for the next 1 year is -89%.